GLP-1 vs Metformin for Weight Loss: What the Evidence Shows

If you've been researching weight loss medications, you've probably encountered both GLP-1 receptor agonists and metformin. Maybe your doctor mentioned one (or both), or perhaps you've seen conflicting information online about which works better. The truth is, these medications work in completely different ways, were designed for different purposes, and produce very different results when it comes to weight loss.

Let's walk through what the evidence actually shows, so you can have a more informed conversation with your healthcare provider about what might work best for your situation.

Understanding What These Medications Actually Are

Before we compare them, it helps to understand what we're talking about.

What Is Metformin?

Metformin has been around since the 1950s and is considered the first-line medication for type 2 diabetes. It works primarily by reducing how much glucose your liver releases into your bloodstream and making your body's cells more sensitive to insulin. It's inexpensive, well-studied, and generally safe for long-term use.

Weight loss was never metformin's primary purpose—it's a diabetes medication that happens to cause modest weight loss in some people as a side effect.

What Are GLP-1 Medications?

GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are newer medications that mimic a natural hormone in your body called glucagon-like peptide-1. This hormone does several things: it signals fullness to your brain, slows how quickly food leaves your stomach, and helps regulate blood sugar.

Unlike metformin, newer GLP-1 medications were specifically studied and approved for weight loss in people without diabetes, not just as diabetes treatments.

The Weight Loss Results: What the Research Shows

This is where the differences become really clear.

Metformin's Weight Loss Effects

Multiple studies show that metformin produces modest weight loss—typically around 2-3% of body weight, or roughly 4-7 pounds for someone weighing 200 pounds. Some people lose a bit more, some lose nothing at all.

A large review of 31 clinical trials found that people taking metformin lost an average of 5.3 pounds over several months compared to placebo. The weight loss tends to plateau after about six months, and many people regain some weight even while continuing the medication.

That's not nothing, especially if you're also working on lifestyle changes, but it's not the dramatic transformation many people hope for.

GLP-1 Weight Loss Results

The numbers here are substantially different. In clinical trials, semaglutide (at the Wegovy dose of 2.4mg weekly) helped people lose an average of 15% of their body weight over 68 weeks—that's about 33 pounds for someone starting at 220 pounds.

Tirzepatide shows even more impressive results, with people losing an average of 15-22% of their body weight depending on the dose, roughly 35-50 pounds for someone weighing 230 pounds.

These aren't just statistically significant differences—they're clinically meaningful ones that can impact health markers like blood pressure, cholesterol, and inflammation.

How They Work Differently in Your Body

The mechanism matters because it explains why the results are so different.

Metformin works mostly on your metabolism and insulin sensitivity. It doesn't directly affect your appetite or how full you feel. Any weight loss comes from improved insulin function and slightly reduced glucose absorption—subtle metabolic shifts rather than changes in hunger signals.

GLP-1 medications, on the other hand, work on multiple pathways. They slow gastric emptying (you feel full longer), they signal satiety to your brain (you feel satisfied with less food), and they reduce food noise (those constant thoughts about eating). Many people describe it as finally having a normal relationship with food—not fighting cravings constantly or thinking about their next meal while eating the current one.

Side Effects: What to Expect

Metformin Side Effects

The most common side effects are gastrointestinal: diarrhea, nausea, stomach upset, and sometimes a metallic taste. These often improve if you start with a low dose and increase slowly, or if you switch to the extended-release version. Most people tolerate it reasonably well long-term.

Rarely, metformin can cause lactic acidosis (a serious buildup of lactic acid) or vitamin B12 deficiency with long-term use, which is why monitoring is important.

GLP-1 Side Effects

GLP-1 medications also commonly cause nausea, sometimes vomiting, diarrhea, and constipation, especially when starting or increasing doses. For many people, these side effects decrease over time as your body adjusts.

The key difference is that GLP-1 side effects tend to be more intense initially but are often manageable with proper dose titration (starting low and going slow). Some people find the nausea significant enough to stop treatment, while others experience minimal discomfort.

Who Is Each Medication Right For?

Metformin May Be a Good Fit If:

• You have prediabetes or type 2 diabetes and need blood sugar control
• You're looking for modest weight support alongside lifestyle changes
• Cost is a major concern (metformin is very affordable, often under $10/month)
• You want a medication with decades of safety data
• You have PCOS and insulin resistance

GLP-1 Medications May Be a Better Choice If:

• You need to lose a significant amount of weight (generally 10%+ of body weight)
• You struggle with constant food cravings and appetite control
• Metformin didn't produce the results you needed
• You have obesity-related health conditions like high blood pressure or sleep apnea
• You're willing to self-inject medication weekly

For Women: What to Consider

Women often face specific challenges with weight loss due to hormonal fluctuations, particularly during perimenopause and menopause when metabolic changes can make weight management more difficult. Research suggests women may respond particularly well to GLP-1 medications during these life stages when traditional diet and exercise become less effective.

If you have PCOS, metformin has been used off-label for years and may help with both metabolic symptoms and modest weight management. However, if significant weight loss is your goal, GLP-1 medications typically produce more substantial results.

For Men: What the Data Shows

Some studies suggest men may lose weight slightly faster on GLP-1 medications, possibly due to differences in body composition and metabolism. However, both men and women see clinically significant results.

Men are also more likely to have undiagnosed prediabetes or metabolic syndrome, making the metabolic benefits of either medication valuable beyond just weight loss. Don't overlook the cardiovascular benefits of GLP-1 medications if you have risk factors like high blood pressure or a family history of heart disease.

Can You Take Both Together?

Yes, and many people do. Metformin and GLP-1 medications work through different mechanisms, so they can complement each other. This combination is particularly common in people with type 2 diabetes who need both blood sugar control and weight loss.

Your healthcare provider can help determine if combination therapy makes sense for your specific situation, though many people find that a GLP-1 medication alone provides the weight loss and metabolic benefits they're looking for.

The Bottom Line

If we're talking purely about weight loss effectiveness, the evidence is clear: GLP-1 medications produce significantly more weight loss than metformin. We're comparing 15-22% body weight reduction versus 2-3%—that's not a small difference.

But that doesn't mean GLP-1 medications are automatically the right choice for everyone. Metformin remains an excellent, affordable option for people with diabetes or prediabetes who need modest metabolic support. It's also a reasonable first step for people who want to see how medication can support their lifestyle changes before committing to a more intensive treatment.

For people who need substantial weight loss, who've struggled with appetite control, or who haven't had success with other approaches, GLP-1 medications represent a genuinely different class of treatment with evidence-backed results.

From the Ozari Care Team

We see many patients who tried metformin first and were disappointed by minimal weight loss, then experienced transformative results with GLP-1 therapy. If you've been on metformin for several months without seeing the changes you hoped for, it may be time to discuss GLP-1 options with your provider. These aren't competing medications—they're different tools for different situations, and finding the right fit for your body and goals is what matters most.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team — licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 25, 2026